Category: wiley

Déjà vu: Double pub in the same issue earns a retraction

biomedchromAlways do a careful reading of your galleys, editors.

We imagine readers of Biomedical Chromatography’s special issue, “Reminiscences of Chang Kee Lim,” did some flipping back and forth when they found the same paper published twice.

Here’s the resulting notice for “Determination of 4-hydroxy-2-nonenal in serum by high-performance liquid chromatography with fluorescence detection after pre-column derivatization using 4-(N,N-dimethylaminosulfonyl)-7-hydrazino-2,1,3-benzoxadiazole”:  Continue reading Déjà vu: Double pub in the same issue earns a retraction

New method sinks newish paper…or does it?

cover_2009_BB_viz_biomassThe timing on a recent retraction of a paper from Biotechnology and Bioengineering makes it a bit difficult to figure out what happened, but here’s a try.

An article first published online May 16th by a group of researchers at Brown University was retracted on June 1st, apparently because a new and better method for analyzing the data was developed…at some point.

The timeline is not exactly clear from the retraction, though we’ve reached out to the author and publisher and will update with any new information.

Here’s the (paywalled) notice for “High-level production of 3-hydroxypropionatein Escherichia coli and Saccharomyces cerevisiae by introducing part of the 3-hydroxypropionate/4-hydroxybutyrate cycle from Metallosphaera sedula”:

Continue reading New method sinks newish paper…or does it?

Second study of widely touted cancer and HIV “cure” retracted

j med virologyLast month, we brought you the story of the retraction of a paper by Nobutu Yamamoto and colleagues about “a protein being used — unapproved by health agencies — to treat diseases including cancer and autism.”

A second paper by the group, about using the protein to treat HIV, has been retracted. Here’s the notice for “Immunotherapy of HIV-infected patients with Gc protein-derived macrophage activating factor (GcMAF),” from the Journal of Medical Virology:
 Continue reading Second study of widely touted cancer and HIV “cure” retracted

“Is Imitation the Sincerest Form of Flattery? Not Without Proper Attribution.”

regional sci policy practiceWe’re going to get a little meta here, so be warned.

Take a look at the headline of this post. For those of you unfamiliar with the symbols to the left and right of the words, those are quotation marks. What that means is that we’ve taken those two sentences from another source. And here is that other source, a blog post from Tahseen Consulting titled — yes, you guessed it, “Is Imitation the Sincerest Form of Flattery? Not Without Proper Attribution.”

Apparently, the last group of authors who liked Tahseen’s words enough to use them did so without that whole attribution thing. Here, let us demonstrate attribution again, this time using the WordPress block-quote function. From the post: Continue reading “Is Imitation the Sincerest Form of Flattery? Not Without Proper Attribution.”

Serial figure fakers have expression of concern upgraded to a retraction

Another retraction has appeared up for frequent fliers Jun Li, Kailun Zhang and Jiahong Xia at Huazhong Science and Technology University in Wuhan, China.

We’ve covered them twice before, for a variety of retractions, corrections, and expressions of concern.

The retraction, in Clinical and Experimental Immunology, upgrades an expression of concern published earlier this year, and is the team’s fourth.

Here’s the notice for “CCR5 blockade in combination with rapamycin prolongs cardiac allograft survival in mice”: Continue reading Serial figure fakers have expression of concern upgraded to a retraction

Unfortunate timing: Journal retracts cover image, citing tsunami in Japan

It’s an unusual move: Pediatric Allergy and Immunology has switched out the cover image in the online versions of its March issue, after realizing that likening allergies to a tsunami while Japan is struggling with the devastating effects of a real-life disaster could be “open to misinterpretation.” From an editor’s note: Continue reading Unfortunate timing: Journal retracts cover image, citing tsunami in Japan

Another stem cell paper retracted, for “breach of established ethical guidelines”

Last week’s big Retraction Watch news — which got us quoted in the New York Times — was a Nature paper by Amy Wagers and Shane Mayack. The now-retracted paper suggested that the aging of stem cells could be reversed, and Blood has issued a notice of concern about a second paper.

Now comes news about another stem cell finding. The International Journal of Urology has retracted a 2009 paper by Japanese researchers who claimed to have used stem cells derived from fatty tissue to treat urinary incontinence in two men. The men had developed bladder problems after undergoing surgery to remove their cancerous prostates.

According to the editor’s note, the article Continue reading Another stem cell paper retracted, for “breach of established ethical guidelines”

Progressive: How the Cochrane Library handles updates-in-progress

Over the summer, while searching for some studies and evidence for various treatments, my wife, a television writer and producer, noticed something she thought unusual enough to flag for me. The titles of a number of Cochrane Library reviews started with “WITHDRAWN.”

The Cochrane Library is the world’s leading publisher of systematic reviews, which gather all of the high-quality evidence on a given subject and offer a rigorous analysis of whether a given test or treatment works. It’s an invaluable resource. (Shameless plug: Join the Association of Health Care Journalists, where I’m treasurer, and access to the $285-per-year Cochrane subscription is included.)

Retraction Watch was curious about what “WITHDRAWN” meant, since “withdrawal” is often used synonymously with retraction. Cochrane updates its reviews regularly, as new evidence surfaces, of course. But these abstracts didn’t say anything about new reviews.

We asked Jen Beal, who handles media relations for Wiley, the Cochrane Library’s publisher. She responded: Continue reading Progressive: How the Cochrane Library handles updates-in-progress